Imaging Features That Portend Development of Geographic Atrophy

Using OCT to identify nascent GA could help prevent vision loss and aid in clinical trial design.

By Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS, Zhichao Wu, BAppSc (Optom), PhD

Cost Effectiveness of Early Detection of Wet Age-related Macular Degeneration

Exploring effective monitoring methods for high-risk conversion patients.

By Samaantar Joshi, BS, Khiem Sy Nguyen, BS, Karen M. Wai, MD, et al.

Considerations in Management of Dry AMD

Patient counseling and logistical considerations are key.

By Karen W. Jeng-Miller, MD, MPH

Subspecialty News March 2024

Trial results in MacTel, AI in DR screening, industry collaborations, and more.

By Rochelle Nataloni, contributing writer

Retina Fellows Convene in Chicago

John T. Thompson, MD, FASRS, delivered the distinguished guest lecture at the 2024 meeting.

By CARL C. AWH, MD

MCO-010 Gene Therapy Improves BCVA in Patients With Advanced RP

The therapy has received both orphan drug and fast track designations from the FDA.

By Jim Gallagher, managing editor

Upfront: An Ounce of Prevention

By Peter K. Kaiser, MD

Uveitis Corner: The Management of Uveitis During Pregnancy and Postpartum

Flare rates can change during and after pregnancy.

By Sruthi Arepalli, MD

Clinical Trial Download: Longer-term Data on New Treatments for Geographic Atrophy

Nuances from extension studies will inform therapeutic decision-making.

By Yasha Modi, MD , Vaidehi S. Dedania, MD, Talia R. Kaden, MD

Coding Q&A: Part C Medicare vs Traditional Medicare

Practice managers must understand the implications of the shifting landscape.

By Brandy H. Sperry, COMT, COE, OCS

New Product Applications: Fully Digital Bausch + Lomb Surgical Visualization Platform Debuts

New technology provides cutting-edge visualization and ergonomic positioning.

By Karen Appold, contributing writer

Clinical Trial Update March 2024

A listing of all active clinical trials in wet AMD, dry AMD, retinal vein occlusion, diabetic macular edema, and uveitis.

Neovascularization in Macular Telangiectasia

Screening and monitoring are critical elements of care.

By Zack Oakey, MD

Office Workflow Challenges With Anti-complement Therapeutics

Pegcetacoplan and avacincaptad pegol 1 year later

By Priya Sharma Vakharia, MD

Eyes Wide Open: Navigating the AI Horizon

The AI revolution can bring practice management and clinical benefits.

By CARRIE JACOBS, COE, CPSS, OCS

Positive Results for EYP-1901 in DAVIO 2, and a Look Forward to Phase 3

A promising new class of medications for neovascular AMD patients

By Carl D. Regillo, MD, FACS, Michael A. Singer, MD

Geographic Atrophy: Patient Conversations, Pearls, and Office Workflows

New GA therapeutics require nuanced patient conversations, changes in office workflows, and vigilance to prevent complications in treated eyes.

By Rishabh Gupta, MD, Mathew W. MacCumber, MD, PhD, Vivek Chaturvedi, MD